北京天坛生物制品股份有限公司 specializes in blood product manufacturing and biopharmaceuticals, focusing on innovations and enhancements in health services, including blood collection and plasma treatments. The company is described as engaged in rural revitalization and social welfare activities.

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include blood intravenous injection immunoglobulin; blood human albumin; blood system intravenous injection; hepatitis B, freeze-dried hepatitis B, and tetanus human immunoglobulin; human immunoglobulin; and other blood products. The company was incorporated in 1998 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. operates as a subsidiary of China National Biotec Group Company Limited.

6001

COM:TIANTANBIO

北京天坛生物制品股份有限公司

Last Close

22.03

22/11 07:00

Market Cap

47.00B

Beta: -

Volume Today

20.09M

Avg: -

locale

market

industry

website

crunchbase

ipo date

peer of

Metrics